Upside Foods Vs Good Meat-launch Details Surprise Many
- 01. Regulatory milestone and launch timing
- 02. Where first sold
- 03. Production footprint and scale plans
- 04. Product types and labeling
- 05. Key partnership and launch strategy
- 06. Illustrative timeline (example)
- 07. Market and consumer context
- 08. Estimated economics and projected volumes (illustrative figures)
- 09. Health, safety, and labeling details
- 10. Quotes and public statements
- 11. Risk factors and adoption barriers
- 12. Comparison snapshot
- 13. Public reaction and media framing
- 14. Frequently asked questions
- 15. What to watch next
Short answer: Upside Foods and GOOD Meat (Eat Just's cultivated-meat arm) began commercial rollouts of USDA- and FDA-cleared cultivated chicken in mid-2023, initially through limited restaurant launches (Upside at Bar Crenn in San Francisco; GOOD Meat with José Andrés's restaurants in Washington, D.C.) with production constrained to licensed California facilities and phased scale-up to grocery and broader foodservice over 12-36 months.
Regulatory milestone and launch timing
The companies received the final U.S. regulatory steps-FDA safety clearance followed by USDA grant of inspection and label approval-on and around June 21, 2023, enabling immediate commercial sales under inspected production conditions.
The initial public rollouts occurred as limited, reservation-only restaurant menu items in late 2023 and early 2024 while both firms continued to commission larger production plants to support wider retail distribution within the following 12-36 months.
Where first sold
Upside Foods' first public placement targeted an upscale San Francisco location, Bar Crenn, operated by chef Dominique Crenn, to introduce a whole-textured cultivated chicken product to diners.
GOOD Meat's initial U.S. placement was announced with restaurateur José Andrés' group in Washington, D.C., leveraging high-profile chef partnerships to manage limited supply and build consumer familiarity.
Production footprint and scale plans
At launch both companies produced cultivated chicken in inspected California facilities; Upside signaled plans for a production site 10-20x larger than its Emeryville plant to reach mass retail economics.
Both firms described staged scale-up: (1) low-volume premium restaurant sales to validate product and labeling, (2) expanded foodservice and QSR partnerships, then (3) grocery and national chains once capacity and cost points allowed.
Product types and labeling
Both companies marketed their items as "cell-cultivated chicken" or similar USDA-approved nomenclature rather than conventional labels; Upside emphasized a 99%-cell whole-textured chicken product for initial menu items.
Early SKUs focused on prepared menu formats (whole-textured chicken dishes, ground or formed proteins) with plans to add familiar grocery formats (breasts, ground, nuggets) as volume and price competitiveness improved.
Key partnership and launch strategy
- High-profile chefs: Upside used Dominique Crenn and GOOD Meat worked with José Andrés to create demand and press visibility.
- Restaurant-first rollout: limited availability to control supply, gather feedback, and refine labeling and operations.
- Gradual retail entry: planned timeline of months to a few years to expand into supermarkets depending on capacity scale and cost reductions.
Illustrative timeline (example)
- June 21, 2023 - FDA/USDA regulatory steps completed, grants of inspection and label approvals issued.
- Q3-Q4 2023 - Limited restaurant service begins (pilot placements in San Francisco and Washington, D.C.).
- 2024 - Commissioning larger production lines; selective foodservice expansion and chef partnerships deepen.
- 2024-2026 - Phased retail introduction as cost and capacity targets are met (timing dependent on scale-up speed).
Market and consumer context
Introducing cultivated meat through premium restaurants is a common strategy to manage early supply constraints while generating press, trained tasting feedback and higher margins that help absorb early production costs.
Regulatory approvals made the United States the second country after Singapore to permit commercial sales of cultivated meat, moving the technology from R&D and pilot trials into consumer-facing commerce.
Estimated economics and projected volumes (illustrative figures)
| Metric | Illustrative figure | Notes |
|---|---|---|
| Initial retail price (per lb) | $35-$70 | Premium launch pricing in restaurants; expected to fall with scale (illustrative). |
| Target mature retail price (per lb) | $8-$12 | Company targets within 3-5 years post scale-up (illustrative). |
| Initial weekly volume (combined) | 2,000-10,000 lbs | Conservative early production capacity across facilities (illustrative). |
| Planned larger facility scale | 10-20x current plant | Upside announced intent for a 10-20x larger plant than Emeryville. |
Health, safety, and labeling details
Regulatory approvals reflect two separate agency roles: the FDA reviewed cell line development and safety, while the USDA handled inspection, labeling, and plant inspection grants for finished product manufacturing.
Both companies received "No Questions" letters from FDA prior to USDA label approval, and the USDA granted inspection and label language that enables the use of terms like "cell-cultivated chicken."
Quotes and public statements
"With this approval, UPSIDE can begin commercial production and sales of its cultivated chicken," Upside Foods said in public comments announcing the regulatory milestone.
GOOD Meat and partners noted the USDA action "marks a decisive moment in the history of food and agriculture," positioning cultivated meat as a lower-resource alternative to conventional animal agriculture.
Risk factors and adoption barriers
Price parity with conventional chicken, public acceptance, supply chain integration, and scaling bioreactor capacity are the primary barriers to rapid grocery penetration; early adopters face novelty premiums and limited distribution.
Labeling clarity and traceability within existing inspection frameworks remain operational hurdles for both foodservice operators and retailers as product lines diversify beyond initial menu items.
Comparison snapshot
| Aspect | UPSIDE Foods | GOOD Meat (Eat Just) |
|---|---|---|
| First U.S. placement | Bar Crenn, San Francisco | José Andrés group, Washington, D.C. |
| Regulatory approvals | FDA safety letter; USDA grant of inspection & label approval | FDA clearance (March 2023); USDA grant of inspection & label approval |
| Initial product focus | Whole-textured chicken (99% cell composition) | Cultivated chicken for restaurant menu items; prior Singapore sales experience |
Public reaction and media framing
Mainstream outlets framed the rollout as a regulatory and symbolic breakthrough that shifts cultivated meat from laboratory novelty into commercial reality, emphasizing chef partnerships and restaurant placements to contextualize availability.
Industry groups highlighted the U.S. becoming the second country after Singapore to permit cultivated-meat sales, pointing to the step's significance for global supply chains and climate-focused protein alternatives.
Frequently asked questions
What to watch next
Key signals to monitor are announcements of new, larger production facilities (capacity and location), expanded foodservice partnerships beyond flagship restaurants, formal retail listings with national chains, and publicly reported unit economics showing rapid price declines.
Regulatory clarifications, additional label language or state-level retail approvals could also affect rollout speed and geographic availability in the next 12-24 months.
Key concerns and solutions for Upside Foods Vs Good Meat Launch Details Surprise Many
When did Upside Foods and GOOD Meat receive U.S. approval?
Both firms cleared the final USDA grant of inspection and label approval around June 21, 2023, following prior FDA safety clearances that validated their cell-cultivation processes.
Where could consumers first buy the products?
Initial sales were limited to select restaurants: Upside at Bar Crenn in San Francisco and GOOD Meat through a partnership with José Andrés' restaurants in Washington, D.C., before planned expansion.
Will these products appear in supermarkets soon?
Retail entry was planned as a phased process dependent on building larger production facilities and achieving lower unit costs; companies projected retail introductions within a 12-36 month window after initial launches (company timelines vary).
How are the products labeled?
USDA label approvals allowed use of terms such as "cell-cultivated chicken," reflecting agency-approved nomenclature and inspection frameworks for cultivated products.
Are the products safe to eat?
FDA issued "No Questions" safety letters for both firms before USDA inspection grants-these are the formal agency steps indicating reviewed safety for the marketed cultivated products.